共 20 条
- [2] RADIATION-RELATED PREDICTORS OF HEMATOLOGIC TOXICITY AFTER CONCURRENT CHEMORADIATION FOR CERVICAL CANCER AND IMPLICATIONS FOR BONE MARROW-SPARING PELVIC IMRT [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1043 - 1047
- [5] TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05): : 1341 - 1346
- [6] Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) : 1678 - 1685
- [8] DISTRIBUTION OF PROLIFERATING BONE MARROW IN ADULT CANCER PATIENTS DETERMINED USING FLT-PET IMAGING [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (03): : 847 - 852
- [10] IMPACT OF BONE MARROW RADIATION DOSE ON ACUTE HEMATOLOGIC TOXICITY IN CERVICAL CANCER: PRINCIPAL COMPONENT ANALYSIS ON HIGH DIMENSIONAL DATA [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : 912 - 919